Gorse GJ, Grimes S, Buck H, Mulla H, et al. A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system. Vaccine 2022 Feb 3. pii: S0264-410X(22)00058.
PMID: 35125219